{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

Vabysmo

Roche Products Limited

{pdf_link}

Information for Patients - Guide to Vabysmo® (faricimab) for the Treatment of Diabetic Macular Oedema (DMO)

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

{pdf_link}

Information for Patients - Guide to Vabysmo® (faricimab) for the Treatment of Macular oedema secondary to Central Retinal Vein Occlusion (CRVO) or Branch Retinal Vein Occlusion (BRVO)

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

{pdf_link}

Information for Patients - Guide to Vabysmo® (faricimab) for the Treatment of Wet (Neovascular) Age-Related Macular Degeneration (AMD)

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

Valdoxan

Servier Laboratories Limited

{pdf_link}

Valdoxan (agomelatine) Liver Function Monitoring Scheme

{healthcare_pro_orange} For Healthcare Professionals
This material (also included in the Prescriber guide) is provided to guide Healthcare professionals in monitoring the liver function of patients before and during treatment with Valdoxan. This material is a scheme detailing how the liver function of patients taking Valdoxan should be monitored.

{pdf_link}

Valdoxan (agomelatine) Patient Alert Card

{healthcare_pro_orange} For Healthcare Professionals
A Patient Card must be provided to each patient who is prescribed Valdoxan and the Prescriber should explain the importance of the liver function monitoring to the patient.

{pdf_link}

Valdoxan (agomelatine) Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals
This material has been developed to increase awareness about the recommendations for use for Valdoxan, in order to minimise the risk of serious liver adverse reactions. The Prescriber Guide includes guidance for Healthcare professionals in monitoring the liver function of patients before and during treatment with Valdoxan. If you require hard copy of the above materials or for further information, please contact Servier Medical Information (telephone: 01753 666409, email: [email protected])

Vanflyta

Daiichi Sankyo UK Limited

{pdf_link}

VANFLYTA - HCP guide: Important information for healthcare professionals about serious risks associated with Vanflyta

{healthcare_pro_orange} For Healthcare Professionals
This HCP guide is: Provided for HCPs to read before prescribing and administering Vanflyta A reminder to distribute a patient Card to any patient receiving Vanflyta treatment for the first time or if asked for a new copy

{pdf_link}

Vanflyta (Quizartinib)- Initial- Patient Alert Card

{healthcare_pro_orange} For Healthcare Professionals
A reminder to distribute a patient Card to any patient receiving Vanflyta treatment for the first time or if asked for a new copy

Vaxchora

Patientric Limited

{pdf_link}

RMM - Patient Guidance

Risk management materials for patients taking Vaxchora

{pdf_link}

RMM Guide for HCPs

{healthcare_pro_orange} For Healthcare Professionals
Risk Management materials guide for HCPs

Velsipity

Pfizer Limited

{pdf_link}

Velsipity (etrasimod) Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
The prescriber checklist is intended to remind the prescriber of important potential risks associated with etrasimod use and recommended tests before and during treatment.

{pdf_link}

Velsipity (etrasimod) Patient card for women of childbearing potential

Patient card designed to enhance the awareness and knowledge of patients of childbearing potential about embryofoetal toxicity in pregnant females exposed to etrasimod and ensure the appropriate use of Velsipity.

{pdf_link}

Velsipity (etrasimod) Patient/Caregiver Guide

The patient/caregiver guide is intended to enhance the awareness and knowledge of patients about etrasimod, including important safety information, and to ensure appropriate use of Velsipity.

Venclyxto

AbbVie Ltd

{pdf_link}

Venclyxto Patient Alert Card

Venclyxto Patient Card with safety information about Venclyxto for patients with Chronic Lymphocytic Leukaemia (CLL). This card contains information for the patient with regards to Tumour Lysis Syndrome and Venclyxto.

VFEND

Pfizer Limited

{pdf_link}

Vfend Patient Alert Card

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

Viagra

Upjohn UK Limited

{pdf_link}

Essential Information for the supply of Viagra Connect

{healthcare_pro_orange} For Healthcare Professionals
This document contains essential information you will need to know and consider when assessing men as suitable candidates for use of VIAGRA connect. Such as understanding erectile dysfunction, who can use Viagra Connect, providing advice and patient supply/case study examples.

{pdf_link}

Viagra Connect Pharmacy Checklist

{healthcare_pro_orange} For Healthcare Professionals
A 2 page optional guide to help pharmacists when assessing men’s suitability for using Viagra Connect

Volibris

GlaxoSmithKline UK

{pdf_link}

Volibris Patient Alert Card

This Patient Alert Card is used to facilitate regular tracking and monitoring of hepatotoxicity and teratogenicity.

Voriconazole

Aspire Pharma Ltd

{pdf_link}

Voriconazole Healthcare Professional Checklist

{healthcare_pro_orange} For Healthcare Professionals
Healthcare Professional Checklist to be completed at each visit.

{pdf_link}

Voriconazole Patient Alert Card

Patient Alert card.

{pdf_link}

Voriconazole Q&A Brochure

{healthcare_pro_orange} For Healthcare Professionals
Healthcare Professional Q&A Brochure

Aurobindo Pharma - Milpharm Ltd.

{pdf_link}

Voriconazole Milpharm HCP Q&A brochure

{healthcare_pro_orange} For Healthcare Professionals
Question and Answer brochure intended for prescribers and other healthcare professionals involved in treatment with Voriconazole. The brochure covers important identified risks of Voriconazole and how they should be mitigated and managed

{pdf_link}

Voriconazole Milpharm Healthcare Professional Checklist

{healthcare_pro_orange} For Healthcare Professionals
Checklist to be completed at each visit with patients being treated with Voriconazole. Each of the three sections include important risk information followed by a series of check boxes to help in the management of patients for whom Voriconazole is being prescribed.

{pdf_link}

Voriconazole Milpharm Patient Alert Card

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

Bowmed Ibisqus Limited

{pdf_link}

Voriconazole HCP Checklist

{healthcare_pro_orange} For Healthcare Professionals
Checklist to be completed at each visit with patients being treated with Voriconazole. Each of the three sections include important risk information followed by a series of check boxes to help in the management of patients for whom voriconazole is being prescribed.

{pdf_link}

Voriconazole HCP Q & A

{healthcare_pro_orange} For Healthcare Professionals
Question and Answer brochure intended for prescribers and other healthcare professionals involved in treatment with voriconazole. The brochure covers important identified risks of Voriconazole and how they should be mitigated and managed

{pdf_link}

Voriconazole Patient Alert card

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

Dr. Reddy's Laboratories (UK) Ltd

{pdf_link}

Voriconazole Healthcare Professional Checklist

{healthcare_pro_orange} For Healthcare Professionals
Each of the three sections includes important risk information followed by a series of check boxes to help in the management of your patient for whom you have prescribed Voriconazole.

{pdf_link}

Voriconazole Healthcare Professional Question & Answer Brochure

{healthcare_pro_orange} For Healthcare Professionals
These questions and answers (Q&A’s) are provided by generic medicine manufacturers for prescribers and other healthcare professionals (HCPs) involved in the treatment of patients with Voriconazole.

{pdf_link}

Voriconazole Patient Alert Card

Voriconazole Patient Alert Card

Pfizer Limited

{pdf_link}

Voriconazole Pfizer Patient Alert Card

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care

VPRIV

Takeda UK Ltd

{pdf_link}

VPRIV- Guide for Homecare Nurse, Patient, Caregiver

Guide for Homecare Nurse, Patient, Caregiver 2023

{pdf_link}

VPRIV-Guide for Treating Physicians

{healthcare_pro_orange} For Healthcare Professionals
Guide for Treating Physicians - 2023 Nov

Vyndaqel

Pfizer Limited

{pdf_link}

Vyndaqel HCP Guide

{healthcare_pro_orange} For Healthcare Professionals
Healthcare professional guide to highlight key information related to prescribing, management, monitoring and safety considerations included in the Risk Management Plan

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?